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Summary: A study is described on the interference of bilirubin with the determination of creatinine in serum
using three automatic analysers i.e. the Technicon Chem-1, the DuPont Dimension and the Baxter Paramax.
In all instruments a kinetic Jaffe reaction is applied. As comparison method we used a HPLC based selected
method.
All methods proved to be sensitive to interference, the Paramax showing the best performance with our set
of specimens.
Results regarding modifications leading to improvement and possible future experiments are discussed.
Introduction
Soon after the introduction of the Technicon Chem-1
clinical chemical analyser in our laboratory, we be-
came involved in discussions with clinicians on the
accuracy of our new creatinine determination, which
was based on the Jaffe reaction and modified as a
continuous procedure. On closer investigation, it was
found that all questionable results could be traced to
icteric specimens. The interference of bilirubin with
the creatinine determination is very well known and
was, of course, also known to us, not only in relation
to our evaluation study (1). However, our investiga-
tions were restricted to bilirubin-enriched specimens,
and therefore to the effects of unconjugated bilirubin,
whereas in daily practice elevated bilirubin is usually
due to conjugated bilirubin. Furthermore, a number
of drugs are also known to interfere. Therefore we
performed a small pilot study with very icteric spec-
imens (total bilirubin varying from 100 to 500 μηιοΐ/ΐ)
in order to obtain more background information on
creatinine and automatic analysers in relation to ic-
teric specimens. As a reference method, we were only
able at that time to use a Fuller's earth modification.
The results were indeed disturbing as can be seen in
figure 1.
We made contact with the Technicon company where
this problem had been under study for some time. A
new reagent formulation was about to be released.
We started a thorough study of our own in the hope
of deciding which method should be used for creati-
nine for both non-icteric and icteric sera on a 24 h
per day basis. Did the problem occur in all icteric
specimens, and was it possible to correct it? Since a
DuPont Dimension was also in operation in our lab-
oratory, we considered whether this instrument might
produce better results.
In the meantime we were invited by Technicon to
evaluate their modification. In view of reported in-
constancies in the Fuller's earth reagent (2), we first
developed a sound reference method for creatinine.
This method, based on HPLC, has been described
elsewhere (3).
We also included the Baxter Paramax analyser, in
order to study a more elaborate version of the state
of the art creatinine methodology. It appears that the
principle used by all manufacturers is the measure-
ment of the rate of the Jaffe reaction.
Later, we were asked by DuPont (The Netherlands)
to compare an open channel Dimension version with
other instruments using our serum bank, because of
critical remarks they had received from customers.
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Materials and Methods
Materials
Creatinine, bilirubin, ascorbic acid and acetone were obtained
from Merck (Germany), human albumin from Behring Werke
(Germany).
Methods
As reference method we used a HPLC-based method. Details
will be described elsewhere (3).
Instrumentation: all analysers, Paramax (Baxter, U. S. A.), Di-
mension (DuPont, U.S.A.) and Chem-1 (Bayer-Technicon,
Germany) were operated according to the manufacturers' in-
structions. The Paramax was calibrated with the Baxter Com-
prehensive Calibrators, levels I and II. The Dimension was
calibrated with patient samples using the Chem-1 results. The
Chem-1 was calibrated with the Setpoint Chem-1 Calibrator
modified as described (4).
A preliminary report on the new Chem-1 creatinine method
was presented at the combined IFCC-AACC meeting in 1990
in San Francisco (5). Briefly, the reagent system was modified
(reversal of picrate and base solutions), together with the inclu-
sion of a selective bichromatic correction. The other two ana-
lysers use a parallel bichromatic algorithm.
The modified Dimension procedure using an open channel is a
two-step method, whereas the commercial version is a one-step
method. It is comparable to the method Du Pont used about
two years ago, but abandoned because it was too slow.
All interference experiments were performed according to the
CERMAB procedure, except that an albumin solution was used
instead of a serum pool (6).
Patient samples
All serum specimens were from various departments in our
hospital. Selection for study was based only on colour. All sera
were characterized by measuring the total bilirubin content
with the Chem-1. A distribution of these bilirubin levels of the
samples in the various comparisons is given in table 1. The sera





For the comparison of the three analysers we used 85
icteric specimens. The total bilirubin content ranged
from 89 to 532 μπιοΐ/l with a distribution as given in
table 1. In figures 2, 3 and 4 the results are compared
with those obtained by HPLC.
In addition to these patient samples, we studied the
influence of unconjugated bilirubin by enriching a
human albumin solution (6). The results of these
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Fig. 1. Comparison of the current Chem-1 creatinine formu-
lation (y-axis) and a Fuller's earth based manual refer-
ence method (x-axis) with 30 icteric samples (total bili-
rubin ranging from about 100 till about 500 μηιοΐ/ΐ).








































A = comparison of Paramax, Dimension and Chem-1 (cur-
rent formulation), see Materials and Methods
Β = comparison of current and new Chem-1 formulation, see
Materials and Methods
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Fig. 2. Comparison of the current Chem-1 creatinine formu-
lation (y-axis) and a HPLC based reference method (x-
axis) with 85 icteric samples (see Results).
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Fig. 3. Comparison of the Dimension creatinine method (y-
axis) and a HPLC based reference method (x-axis) with
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Fig. 4. Comparison of the Paramax creatinine method (y-axis)
and a HPLC based reference method (x-axis) with 85
icteric samples (see Results).
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Fig. 5. The influence of unconjugated bilirubin (stocked human




* = Chem-1 (current)
Evaluation of the Chem-1 creatinine modifi
cation
It is beyond the scope of this article to report exten-
sively on the analytical aspects of the new method.
Briefly, we found the following:
ninety-six, non-icteric specimens, covering an equally
distributed range from 50 — 1500 μπιοΐ/l were meas-
ured with both cassettes (current and new) at the
same time, and separately by HPLC. For calibration
of the Chem-1 the same slope and intercept for both
methods were used. Both methods were found to be
linear over this range and the correlations with HPLC
excellent and almost identical. The coefficients of
variation, measured over a 10-day period, were 2.9 vs
2.5% (current vs new) for the lower value (140 μηιοΐ/l)
and 1.9 vs 1.5% for the higher (750 μπιοΐ/ΐ).
Table 2 gives information on the interference of bili-
rubin (unconjugated), haemoglobin, lipids, acetone
and ascorbic acid.
Tab. 2. Some interference data on both Chem-1 formulations
















!) Influence moderate at above normal creatinine concentra-
tions
In addition, 144 icteric patient samples were studied
with bilirubin concentrations ranging from 58 to 564
μηιοΐ/ΐ. In figures 6 and 7 the comparisons of both
cassettes with HPLC are shown. The bilirubin con-
tents are given in table 1.
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Creatinine (serum, HPLC) [μηπΟΐ/Ι]
Fig. 6. Comparison of the current Chem-1 creatinine formu-
lation (y-axis) and a HPLC based reference method (x-
axis) with 144 icteric samples (see Results).
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Fig. 7. Comparison of the new Chem-1 creatinine formulation
(y-axis) and a HPLC based reference method (x-axis)













Creatinine (serum, HPLC) [μητιοΙ/Ι]
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Fig. 8. Comparison of the current Dimension creatinine
method (y-axis) and a HPLC based reference method
(x-axis) with 99 icteric samples (see Results).
Comparison two creatinine methods on the
Dimension
Ninety-nine icteric samples (the total bilirubin con-
tents are also given in tab. 1) were compared with
HPLC, the results of which are depicted in figures 8
and 9.
Discussion
This study was initiated for practical reasons. We were
faced by situations, in which the results of our routine
creatinine determination did not fit the clinical pic-
ture. Sometimes the clinicians were right, sometimes
they were not. In our laboratory we see serum samples
with elevated bilirubin levels 5 — 10 times per day
(total bilirubin higher than 50 μηιοΐ/l). Normally only
total bilirubin is requested. Therefore only these re-
sults were used and no effort was made at this point
to subdivide into bilirubin fractions. This may be
worthwhile in a future study.
It is known that the Jaffe reaction is susceptible to
interference. The latest edition of Young's "Effects of
Drugs on Clinical Laboratory Tests" contains a num-
ber of pages on this problem (7). From this list it is
very clear that bilirubin, the starting-point of our
study, is not the only interferent. This is also what we
experienced, and it makes the problem even more
frustrating. However, the visible colour of elevated
bilirubin in serum is a good means of selecting samples
for study.
It is known from the literature that the speed of
analysis is improved by measuring the rate of the
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Fig. 9. Comparison of the revised Dimension creatinine
method (y-axis) and a HPLC based reference method
(x-axis) with 99 icteric samples (see Results).
also reports describing the circumvention of the influ-
ence of some interferents. Important factors men-
tioned are: picrate and base concentrations, reaction
time and bichromatic measurement (9 — 12). Modern,
high-volume analysers employing the Jaffe reaction
can only use a kinetic version of the analysis. The
reaction conditions represent a compromise designed
to fulfil certain criteria with regard to speed of anal-
ysis, accuracy and precision. Sometimes the user is
left with a flagged result indicating that there is a
problem. In cases of interference it generally means
that a back-up method is needed.
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From figures 2, 3, 4, and 5 it is clear that the current
Chem-1 creatinine method has the largest bias with
our set of icteric specimens and that, with some ex-
ceptions, the Paramax results seem the most accurate,
although the differences between the Paramax and
the Dimension are generally not very pronounced.
Although the numerical values are not given, it is
striking that strongly deviating results in one instru-
ment are often correct in the other two analysers. In
our opinion this can be attributed to the reaction
conditions, which differ considerably in all instru-
ments.
Concerning the new Chem-1 creatinine formulation,
it is quite clear from figures 6 and 7 that there is an
improvement, although there appears to be some kind
of overcompensation. It is still disappointing that,
especially in the lower range, which is clinically im-
portant, a number of outliers still exists.
Technicon claims that the new formulation, which
will be commercially available in 1992, also has im-
proved stability. This may be true, but we have not
thoroughly checked the stability of the formulation,
because of the limited length of our study and also
because we focussed our attention on the interference
of bilirubin. Regarding the analytical performance for
non-icteric specimens, both cassettes are more or less
comparable in our opinion and also acceptable.
The question arises of whether we will be satisfied
when the new formulation, together with the new
software, is released. The answer is no. This can best
be explained by considering table 3 and figure 10.
Tab. 3. Results obtained from 10 neonatal serum pools. All






























































In table 3 the various data on ten neonatal specimens
are given. It is clear that the results of both cassettes
are totally unacceptable. Figure 10 gives an exploded
view of figure 7 and shows a very critical range of
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Fig. 10. Exploded part of figure 7.
Concerning the software the Chem-1 has a number
of possibilities which can be related to the reaction
conditions and which can be studied. We therefore
discussed the results of our study with Technicon
which resulted in the development of modified soft-
ware in order to improve the bichromatic correction.
With the same modified reagent formulation and this
specially developed software we found in a pre-study
performed with 82 icteric speciments (total bilirubin
ranging from 104 up to 570 μιηοΐ/ΐ) a much better
correlation with HPLC. These and the measurements
regarding the influence of other interfering factors
will be published later on.
The same holds true for the Dimension. Looking from
a "high" standpoint figures 8 and 9 are comparable,
i.e. many accurate results and a small number of
outliers. More detailed information from the numer-
ical values reveals that deviating results in one ver-
sions are correct in the other. So in fact a comparable
invitation to DuPont.
The overall conclusion based on our findings de-
scribed above is rather negative judging from profes-
sional standards on accuracy in relation with the
analysis of all patient samples, no matter what the
interfering factor may be. In this respect we can
concur with Spencer who, in his excellent review ar-
ticle on the analytical aspects of the creatinine esti-
mation, concludes by saying:
"Whilst kinetic methods in general have brought
about marginal improvements in precision and spec-
ificity, it is probably fair to say that these methods
still suffer from interference problems which are un-
likely to be resolved by the kinetic approach" (8).
He expects that the solution will come by applying
some kind of enzymatic approach. He may be right
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although his expectation has not been yet fulfilled at
the moment (13). In the mean time, by filling the gap
between the state of the art now and the ideal future
solution, it is still worthwile to consider bichromatic
correction mechanisms by applying various algo-
rithms because there are no other ways at the moment
(12). Modern analysers equipped with sophisticated
computer facilities ought to be capable of these items.
It should be stressed that quantitative knowledge on
the analytical influence of at least the most common
interferents, and hopefully the absence of this influ-
ence, in the modern closed systems, is needed.
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